Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
User account menu
  • Search
  • Menu
  • About Us
    • Board of Trustees
      • Joerg Reinhardt, Ph.D.
      • Ann Aerts, M.D.
      • Dr. Jo Ivey Boufford
      • Lutz Hegemann, M.D., Ph.D.
      • Prof. Peter Piot, M.D.
    • Our Team
      • Johannes Boch
      • Cristina Haffner
      • Jason Shellaby
      • Lucy Setian
      • Sarah Des Rosiers
      • Xavier Sutter
    • Our partners
    About Us
  • Transforming population health
    • Cardiovascular population health initiative
    • AI4BetterHearts
    • AI in health policy
      • Broadband Commission Working Group on Digital and AI in Health
      • HealthTech Dialogue Hub
    • HealthTech Innovation
      • Brazil COVID-19 response
      • AI4Leprosy
    Transforming Population Health
  • Urban Population Health Toolkit
    • Quality of care
    • Ensure access
    • Policy reform
    • Leverage data and digital
    • Intersectoral collaboration
    • Ensure local ownership
    Urban Population Health Toolkit
  • Past programs
    • Better Hearts Better Cities
      • Community-based Hypertension Improvement Project (ComHIP)
      • Communities for Healthy Hearts
      • KaziBantu (Healthy Schools for Healthy Communities)
    • Leprosy and malaria elimination
      • The Leprosy Alert and Response Network System (LEARNS)
      • Leprosy Post-Exposure Prophylaxis (LPEP) program
      • Malaria Targeted Parasite Elimination Strategy
    • Digital Health
      • Ghana Telemedicine
      • Telemedicine Toolkit
      • Integrated e-Diagnostic Approach
    Past Programs
  • Media Center
    • News Archive
    • Media Library
    • Stories
    Media Center
Homepage
Date range
  1. Home
  2. Media Center
  3. Media Library

Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme

Back to Previous Page

LPEP explored the feasibility of combining three key interventions against leprosy: tracing contacts newly diagnosed patients with leprosy; screening the traced contacts for leprosy; and administering SDR to eligible contacts.

Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme (PDF 393.02 KB)

Related Items

  • Document
    Leprosy, Publication
    Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective
  • Document
    Leprosy, Publication
    An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia
  • Document
    Leprosy, Publication
    Minimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide
Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2021 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience